Eevia Health PLC is a manufacturer of health-promoting extracts extracted from berries, mushrooms, and bark from the Nordic forests. Its products include Bilberry Extracts, Chaga Extracts, Pine Bark Extracts, and Lingonberry extracts among others.
2017
29
Last FY Revenue $0.2M
Last FY EBITDA -$36K
$2.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Eevia Health achieved revenue of $0.2M and an EBITDA of -$36K.
Eevia Health expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Eevia Health valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $0.2M | XXX | XXX | XXX |
Gross Profit | XXX | $0.1M | XXX | XXX | XXX |
Gross Margin | XXX | 52% | XXX | XXX | XXX |
EBITDA | XXX | -$36K | XXX | XXX | XXX |
EBITDA Margin | XXX | -19% | XXX | XXX | XXX |
EBIT | XXX | -$0.1M | XXX | XXX | XXX |
EBIT Margin | XXX | -73% | XXX | XXX | XXX |
Net Profit | XXX | -$0.2M | XXX | XXX | XXX |
Net Margin | XXX | -112% | XXX | XXX | XXX |
Net Debt | XXX | $0.1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Eevia Health's stock price is SEK 0 (or $0).
Eevia Health has current market cap of SEK 15.9M (or $1.6M), and EV of SEK 22.7M (or $2.3M).
See Eevia Health trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$2.3M | $1.6M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Eevia Health has market cap of $1.6M and EV of $2.3M.
Eevia Health's trades at 12.7x EV/Revenue multiple, and -65.9x EV/EBITDA.
Equity research analysts estimate Eevia Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Eevia Health's P/E ratio is not available.
See valuation multiples for Eevia Health and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $1.6M | XXX | $1.6M | XXX | XXX | XXX |
EV (current) | $2.3M | XXX | $2.3M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 12.7x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | -65.9x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | -17.4x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -8.0x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -14.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialEevia Health's revenue per employee in the last FY averaged $6K, while opex per employee averaged $8K for the same period.
Eevia Health's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Eevia Health's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Eevia Health and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | -19% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $6K | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $8K | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 125% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Agthia Group | XXX | XXX | XXX | XXX | XXX | XXX |
Acomo | XXX | XXX | XXX | XXX | XXX | XXX |
ForFarmers | XXX | XXX | XXX | XXX | XXX | XXX |
JDE Peets | XXX | XXX | XXX | XXX | XXX | XXX |
Sligro Food Group | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Eevia Health acquired XXX companies to date.
Last acquisition by Eevia Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Eevia Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Eevia Health founded? | Eevia Health was founded in 2017. |
Where is Eevia Health headquartered? | Eevia Health is headquartered in Sweden. |
How many employees does Eevia Health have? | As of today, Eevia Health has 29 employees. |
Is Eevia Health publicy listed? | Yes, Eevia Health is a public company listed on SAT. |
What is the stock symbol of Eevia Health? | Eevia Health trades under EEVIA ticker. |
When did Eevia Health go public? | Eevia Health went public in 2021. |
Who are competitors of Eevia Health? | Similar companies to Eevia Health include e.g. Agthia Group, Acomo, ForFarmers, JDE Peets. |
What is the current market cap of Eevia Health? | Eevia Health's current market cap is $1.6M |
Is Eevia Health profitable? | Yes, Eevia Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.